Stan Gerson, MD
Director, Case CCC
Sequester Impact on Biomedical Research
Dear Cancer Center Community:
Please consider a sending a short note to as many members of the Ohio congressional caucus as you can to voice your opinion on how the sequester will impact your research. The most convenient method to contact your represenatives is through email (a list is below). Please send your message in the two weeks to ensure it will impact the vote that takes place in early September. You may also consider contacting those outside your district via social media, such as Facebook and Twitter. Finally, please review this compendium of views published in Cell earlier this month.
A sample message could be similar to the following:
Dear Sen./Rep. XXX:
My work in cancer research is focused on XXX. This work is severely affected by the sequester reduction of support to the NCI and NIH. Cancer research is a national priority, and the sequester is eating into every aspect of research including innovative discoveries and care, identification of new genetic abnormalities, efforts to understand familial pre-disposition to cancer, the search for new drugs, and the introduction of these new discoveries to patients through clinical trials. Further, lack of federal funding prevents the training of the next generation of scientists who will make the future discoveries.
Research is a major driver of employment and commercialization in the northern Ohio region. In addition, the United States has been the international leader in cancer research, and this lead is being severely eroded.
Please work to repeal the sequester and to restore full funding to the NIH so that we may carry on our efforts to improve the lives of cancer patients.
Contact Information for Ohio Senators and Representatives:
Sen. Robert Portman
Sen. Sherrod Brown
Rep. Steve Chabot (District 1)
Rep. Brad Wenstrup (District 2)
Rep. Joyce Beatty (District 3)
Rep. Jim Jordan (District 4)
Rep. Bob Latta (District 5)
Rep. Bill Johnson (District 6)
Rep. Bob Gibbs (District 7)
Rep. John Boehner (District 8
Rep. Marcy Kaptur (District 9)
Rep. Michael Turner (District 10)
Rep. Marcia Fudge (District 11)
Rep. Pat Tiberi (District 12)
Rep. Tim Ryan (District 13)
Rep. David Joyce (District 14)
Rep. Steve Stivers (District 15)
Rep. Jim Renacci (District 16)
Case CCC Annual Scientific Retreat - Survey
Last week we sentout a special wrap-up message about the Case CCC Annual Scientific Retreat. The message also contained a link to a feedback survey. Please take this short survey. We will use the information to plan future events and retreats so they can better serve our members.
Head-to-Head Matchup Shows Adjuvant Taxane Schedules Equally Effective
ASCO Post - Jul 25, 2013
In the treatment of early breast cancer, outcomes are equivalent whether paclitaxel is delivered weekly or every 2 weeks, though the weekly schedule may be better tolerated, according to the results of a phase III trial presented at the 2013 ASCO Annual Meeting. "The progression-free survival curves lie right on top of each other. With either schedule you get equivalent outcomes, but weekly paclitaxel is less toxic for most patients," said G. Thomas Budd, MD, a staff physician at the Cleveland Clinic's Taussig Cancer Institute.
Women's Height Linked to Cancer Risk; Don't Worry About the Statistics, Researcher Says
The Plain Dealer - Jul 25, 2013
If you're a postmenopausal woman and you're tall, you have a greater risk for developing cancer. That's the finding of research published online today in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research...One obvious risk factor for developing cancer is if someone has more body surface area, said Dr. Mikkael Sekeres, a hematologist/oncologist at the Cleveland Clinic Taussig Cancer Institute.
Ex-Phillies Wonder if Stadium is to Blame for Players' Brain Cancer
USA Today - Jul 22, 2013
A lot of people, former Phillies included, want to know if the illnesses are just bad luck or if there is some sort of connection – perhaps to Veterans Stadium, the multipurpose sports venue that was home to the franchise from 1971 to 2003 and demolished in 2004..."Can I say definitively that it's a fluke? No," said Jill Barnholtz-Sloan, a Cleveland-based brain-tumor epidemiologist who does research at Case Western Reserve University.
Faculty Search: Director of the Office of Cancer Disparities Research at Case Comprehensive Cancer Center
The Case Comprehensive Cancer Center invites applications and nominations for a leadership position at the level of Associate or Full Professor to lead a new Office of Cancer Disparities Research. The charge of this new position is to reduce and eliminate cancer disparities through orchestrated efforts in research, education and outreach. Experience and demonstrated commitment to reducing disparities among poor urban communities and African American communities is particularly desirable. The research program will integrate into the Center's Cancer Prevention Program, and other scientific programs in the Center. Visit the Cancer Center website for more information and for application instructions.
NSG Mice Available to Purchase
The Athymic Animal & Xenograft Core Facility now has NSG mice available to purchase for $85 each. Please contact the facility for more information.
Clinical Research Scholar Career Development Training Opportunity
The Clinical and Translational Science Collaborative (CTSC) is accepting applications for the KL2 Program. This program is designed to train the nation's future leaders in clinical and translational research, and is part of the NIH Roadmap aimed at "re-engineering the clinical research enterprise." Each scholar will embark on a four-year program of intensive training in multidisciplinary team-based, patient-oriented clinical research, combining an innovative curriculum with mentored research experiences. Applications are encouraged from physicians, nurses, dentists, social and behavioral scientists, engineers, biostatisticians, epidemiologists, bioethicists and other professionals with expertise relevant to clinical research.
Information sessions are scheduled for Cleveland Clinic (August 26), MetroHealth (September 13), and CWRU (October 9). Contact Beth Spyke to register and for more information.
Prevent Cancer Foundation
The Prevent Cancer Foundation 2013 Grant and Fellowship application cycle is open. The Foundation supports research that demonstrates potential for impact on cancer prevention.
Deadline: August 21
Avon Breast Health Outreach Program
The Avon Breast Health Outreach Program is accepting applications from non-profit organizations for grants to conduct outreach, provide education on breast health and breast cancer screening, link medically underserved women to health care providers and clinical screening services, and work to ensure that they obtain any necessary follow-up care.
Deadline: August 23
Susan G. Komen
Susan G. Komen is accepting applications for the following funding opportunities:
American Cancer Society Institutional Research Grant (IRG) Awards
The Case CCC, with funds from its American Cancer Society Institutional Research Grant, will provide seed money to foster cancer research by junior faculty who have no current national grant support of their own. Investigators in the CWRU School of Medicine and Cleveland Clinic Lerner College of Medicine as well as in other schools and colleges in the University are eligible. Grants, not to exceed $30,000, will be awarded to investigators who intend to gather preliminary data to be used in seeking future and independently funded programs.
IRG pilot project grants are intended to support independent, self-directed investigators early in their careers (assistant professor or equivalent). Applicants for the pilot project grants should be within six years of their first independent research or faculty appointment and eligible to apply for an independent national competitive research grant, but cannot currently hold such a grant. Recipients of IRG pilot project grants must be, at the time of the application, citizens or noncitizen nationals of the United States or its possessions and territories, or must have been lawfully admitted to the United States for permanent residence at the time of application.
LOI Deadline: August 12
Application Deadline: September 13
PREVIOUSLY ANNOUNCED OPPORTUNITIES
American Cancer Society Clinical Research Professor
AACR Award for Outstanding Achievement in Chemistry in Cancer Research
Case CCC Protocol Specific Research Support (PSRS)
International Union Against Cancer (UICC) International Cancer Technology Transfer Fellowships
NIH BULLETIN – Notices and Funding Opportunities
Gillian Irwin Todd
11100 Euclid Avenue, Wearn 149
Cleveland, Ohio 44106-5065
HELP US HELP YOU!
If you have a new grant, recently won an award, or have other newsworthy items, please let us know so we can publicize them in the newsletter and other media outlets. You deserve the accolades!
Send items to firstname.lastname@example.org.
Hematology and Oncology Division Research Conference
Jennifer Eads, MD
Assistant Professor, Div. of Hem/Onc
Topic: Overview of Pancreatic Cancer
8 am Lerner Tower B-151
Cancer Center Research in Progress will resume in September
Taussig Cancer Institute Grand Rounds will resume in September
Hematology and Oncology Fellows Conference
8 am Wearn 137
UPCOMING CANCER CENTER SYMPOSIUMS & EVENTS
ADDITIONAL UPCOMING SEMINARS & EVENTS
MSC 2013: Adult Stem Cell Therapy & Regenerative Medicine
Cleveland Marriott Downtown at Key Center
National GvHD Health Symposium
Embassy Suites Cleveland-Rockside